Back to today’s briefing

Story perspectives

CVS Health: Major Stake Shift Amid Strong Earnings

1/30/2025

29 6

Summary

Story summary

Mount Yale Investment Advisors significantly cut its CVS Health shares by 93.7%, now holding 5,915 shares valued at $266,000.
In contrast, Assetmark Inc. increased its stake in CVS Health by 9.7%.
CVS Health posted an EPS of $1.09, surpassing estimates, and announced a quarterly dividend of $0.665.
Analysts maintain mixed ratings, with a consensus of "Moderate Buy" and an average target price of $68.12.

History

Historical Context

Mount Yale Investment Advisors' drastic reduction of CVS Health shares mirrors historical investor reactions during economic downturns. In the late 1990s, similar sell-offs occurred amid tech bubble bursts, reflecting a lack of confidence. Current mixed analyst ratings suggest a cautious approach, reminiscent of past volatility in healthcare stocks during market shifts.

1 of 2

Story summary

Mount Yale Investment Advisors significantly cut its CVS Health shares by 93.7%, now holding 5,915 shares valued at $266,000.
In contrast, Assetmark Inc. increased its stake in CVS Health by 9.7%.
CVS Health posted an EPS of $1.09, surpassing estimates, and announced a quarterly dividend of $0.665.
Analysts maintain mixed ratings, with a consensus of "Moderate Buy" and an average target price of $68.12.

1 / 2